LifeStance Survey Finds Women Want Mental Healthcare Built Into Perimenopause and Menopause Care

Rhea-AI Summary

LifeStance Health (LFST) released results from a survey of 1,000 women born between 1960-1990 who are experiencing or suspect perimenopause or menopause. The survey highlights that 33% did not know perimenopause can cause mental health symptoms, while many report severe anxiety (66%) and depression (54%).

According to LifeStance, 83% of respondents who tried therapy and 82% who tried prescribed medications such as antidepressants or estrogen found them helpful. Nearly half (47%) believe mental healthcare should be standard in perimenopause care, and 59% would be more likely to seek it if they knew it could significantly improve symptoms.

Market Context

LFST's recent earnings announcement was followed by a 2.8% 24-hour move, providing a comparison poin...

Analysis

LFST's recent earnings announcement was followed by a 2.8% 24-hour move, providing a comparison point for this survey. The article adds care-seeking signals, while Net Selling insider activity remains a risk.

Key Figures

Survey Sample: 1,000 women Mental Health Unawareness: 33% Severe Anxiety: 66% +5 more

8 metrics

Survey Sample 1,000 women Perimenopause or menopause survey

Mental Health Unawareness 33% Respondents unaware perimenopause can cause mental health symptoms

Severe Anxiety 66% Respondents describing anxiety as somewhat or extremely severe

Severe Depression 54% Respondents describing depression as somewhat or extremely severe

Helpful Mental Healthcare 83% Respondents who sought mental healthcare and found it helpful

Increased Care-Seeking Likelihood 59% Would be more likely to seek care if benefits were known

Standard-Care Support 47% Agree mental healthcare should be standard in perimenopause care

Lost Work Productivity Cost $1.8 billion annually 2023 Mayo Clinic study estimate for the U.S. economy

Historical Context

5 past events · Latest: Aug 06 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 06	Q2 earnings report	Positive	+2.8%	Revenue growth, profitability, raised outlook, and new share repurchase authorization
Jul 16	Earnings call scheduling	Neutral	+2.6%	Company scheduled its second-quarter earnings release and conference call
May 07	Secondary public offering	Negative	-13.0%	Selling stockholders priced 35 million shares without company proceeds
May 07	Secondary offering launch	Negative	-13.0%	Selling stockholders announced a 35 million-share offering
May 07	Q1 earnings report	Positive	+20.2%	Revenue growth, profitability, cash generation, and raised full-year guidance

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

LFST's recent earnings and scheduling announcements were followed by gains, while secondary offering announcements were followed by declines.

Key Terms

perimenopause, menopause, antidepressants, estrogen

4 terms

perimenopause medical

"perimenopause can cause mental health-related symptoms"

The phase leading up to menopause when a person’s hormone levels and menstrual cycles change, causing symptoms such as hot flashes, sleep disruption, mood shifts and irregular periods. Investors track perimenopause because it drives demand for medical treatments, over-the-counter products, workplace accommodations and health services—think of it like a market-shaping shift in customer needs and labor productivity as a population moves from one long-term life stage to another.

menopause medical

"women experiencing perimenopause or menopause"

Menopause is the natural stage in a person’s life when menstrual periods stop permanently because the ovaries reduce production of hormones like estrogen and progesterone; it is typically diagnosed after 12 consecutive months without a period. Investors care because menopause drives demand for medical treatments, diagnostic services, over‑the‑counter products and workplace accommodations, similar to a market shift when a large customer group changes its needs, affecting revenue and product strategies across health, consumer and employer sectors.

antidepressants medical

"prescribed medications like antidepressants and estrogen"

Medications prescribed to treat clinical depression and related mood disorders by changing brain chemistry that affects mood, sleep, appetite, and thinking. Investors watch them because their development, clinical trial results, patent status, regulatory approvals, and sales affect drugmakers’ revenue and valuation—think of them like a product line whose performance and legal protections determine a company’s future earnings and market risk.

estrogen medical

"prescribed medications like antidepressants and estrogen"

Estrogen is a group of naturally occurring hormones that regulate reproductive systems, bone health, and other body functions in both women and men. For investors, estrogen matters because therapies that replace, mimic, block, or measure these hormones are central to drugs, medical devices, diagnostics, and hormone-related clinical trials; think of estrogen like a master thermostat that, when adjusted by a treatment, can change demand and approval prospects across several healthcare markets.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

One in Three Women Don't Know Perimenopause Can Cause Anxiety, Depression and Mood Changes; Majority Who Seek Mental Healthcare Find It Helpful 

SCOTTSDALE, Ariz., Aug. 11, 2026 /PRNewswire/ -- A LifeStance Health survey of 1,000 women experiencing perimenopause or menopause released today reveals this life stage carries an unexpected mental health toll, as one in three women (33%) report being unaware that perimenopause can cause mental health-related symptoms.

While respondents describe their anxiety (66%) and depression (54%) as somewhat or extremely severe, most women (83%) who seek mental healthcare like therapy find it helpful.

Additionally, 59% of women say they would be more likely to seek mental healthcare if they knew it could significantly improve their symptoms, and nearly half (47%) agree mental healthcare should be a standard part of perimenopause care.

Left unaddressed, perimenopause and menopause symptoms carry consequences not just for the women who are experiencing them, but for employers and health systems. A 2023 Mayo Clinic study found menopause symptoms cost the U.S. economy an estimated $1.8 billion annually in lost work productivity and $26.6 billion when healthcare costs are factored in, reinforcing the need for accessible, integrated mental healthcare throughout these life transitions.

Dr. Stephanie Eken, Chief Medical Officer, LifeStance Health, said: "Women's mental health needs change across their life stages, and perimenopause and menopause are among the biggest transitions of all. Specialized, life-stage-specific care should be standard practice, and I believe the organizations that build care around this reality, rather than taking a one-size-fits-all approach, will define the next era of women's health." 

LifeStance delivers mental healthcare tailored to women's needs across the lifespan, with clinicians trained in perimenopausal, menopausal, perinatal and reproductive mental health. LifeStance also partners with primary and women's health providers to deliver integrated care and offers in-person and virtual visits to meet women where they are. To learn more or schedule an appointment, visit LifeStance.com.

Key findings: 

Women see value in mental healthcare as a standard part of perimenopause and menopause care. 

• The vast majority (83%) of respondents who tried therapy to address their mental health symptoms related to perimenopause or menopause found it helpful. 
• Nearly half (47%) believe therapy or mental healthcare should be a standard part of perimenopause care. 
• Fifty-nine percent said they would be more likely to seek mental healthcare if they knew it could significantly improve their symptoms. 
• Of women who tried prescribed medications like antidepressants and estrogen, 82% found them helpful. 

Awareness gaps remain around the connection between perimenopause, menopause and mental health. 

• One in three (33%) respondents did not know perimenopause can cause mental health symptoms. 
• Nearly half (49%) were surprised to learn mental health symptoms associated with perimenopause and menopause can last several years. 
• Twenty-two percent were surprised to learn perimenopause can occur shortly after childbirth. 

Perimenopause and menopause symptoms could be misattributed to other conditions. 

• Nearly three-quarters (74%) had symptoms for six months or longer before suspecting they were experiencing perimenopause or menopause, while just over one-quarter (27%) recognized it within six months.
• Prior to realizing they were experiencing perimenopause or menopause, respondents thought they were experiencing anxiety (49%) or depression (39%) as a standalone health condition.
• More than one-third (36%) of respondents were surprised to learn perimenopause and menopause symptoms can mask as a standalone mental health condition.

Mental health symptoms during perimenopause and menopause can significantly affect daily life. 

• Two-thirds of women experiencing perimenopause or menopause described their anxiety (66%) and irritability (66%) as somewhat or extremely severe, while nearly one-quarter (24%) described these symptoms as not very severe.
• More than half of respondents described their mood swings (62%) and depression (54%) as somewhat or extremely severe, while about one-quarter described their mood swings (26%) and depression (30%) as not very severe.
• More than one in three respondents (35%) said perimenopause or menopause had a slight to significant negative impact on their overall mental health, and 42% reported it had a negative impact on their mood. Conversely, nearly one-third (32%) reported no impact on their overall mental health, and 22% reported no impact on their mood.

Methodology
The data is based on a survey conducted by Dynata on behalf of LifeStance Health in late June 2026. The survey analyzed responses from 1,000 women born between 1960-1990 who confirmed they currently have, or suspect they have, perimenopause or menopause to better understand the connection and impact to mental health.

ABOUT LIFESTANCE HEALTH
Founded in 2017, LifeStance (NASDAQ: LFST) is reimagining mental health. We are one of the nation's largest providers of virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental healthcare. LifeStance and its supported practices employ more than 8,500 psychiatrists, advanced practice nurses, psychologists and therapists and operate across 33 states and more than 550 centers. To learn more, please visit www.LifeStance.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lifestance-survey-finds-women-want-mental-healthcare-built-into-perimenopause-and-menopause-care-302847433.html

SOURCE LifeStance Health

FAQ

What did the August 2026 LifeStance (LFST) survey reveal about perimenopause and mental health?

The survey showed many women face significant mental health symptoms during perimenopause and menopause, with limited awareness of the connection. According to LifeStance, 66% reported somewhat or extremely severe anxiety and 54% reported similarly severe depression, underscoring the need for integrated mental healthcare.

How many women in the LifeStance (LFST) 2026 survey found therapy helpful for perimenopause-related mental health symptoms?

According to LifeStance, 83% of respondents who tried therapy for perimenopause- or menopause-related mental health symptoms found it helpful. This suggests many women perceive clear benefits from professional mental healthcare when managing anxiety, depression, irritability and mood swings linked to this life stage.

What awareness gaps about perimenopause did LifeStance (LFST) identify in its June 2026 survey?

The survey found sizeable knowledge gaps around perimenopause and mental health. According to LifeStance, 33% of women did not know perimenopause can cause mental health symptoms, and 49% were surprised these symptoms can last several years, indicating substantial educational needs.

How often were perimenopause and menopause symptoms misattributed in the LifeStance (LFST) survey?

Misattribution was common among respondents before they recognized perimenopause or menopause. According to LifeStance, 74% had symptoms for six months or longer before suspecting perimenopause, and many instead believed they were experiencing standalone anxiety (49%) or depression (39%) as separate conditions.

What proportion of women want mental healthcare integrated into perimenopause care, according to LifeStance (LFST)?

Nearly half of surveyed women support integrating mental healthcare into perimenopause care. According to LifeStance, 47% believe therapy or mental healthcare should be a standard part of perimenopause treatment, and 59% would be more likely to seek care if they knew it could significantly improve symptoms.